Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Recognition of allergic conjunctivitis in patients with allergic rhinitis.

Williams DC, Edney G, Maiden B, Smith PK.

World Allergy Organ J. 2013 Feb 12;6(1):4. doi: 10.1186/1939-4551-6-4.

2.

Sublingual immunotherapy for treating allergic conjunctivitis.

Calderon MA, Penagos M, Sheikh A, Canonica GW, Durham S.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD007685. doi: 10.1002/14651858.CD007685.pub2. Review.

PMID:
21735416
3.

Clinical practice guideline: Allergic rhinitis.

Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, Dawson DE, Dykewicz MS, Hackell JM, Han JK, Ishman SL, Krouse HJ, Malekzadeh S, Mims JW, Omole FS, Reddy WD, Wallace DV, Walsh SA, Warren BE, Wilson MN, Nnacheta LC; Guideline Otolaryngology Development Group. AAO-HNSF.

Otolaryngol Head Neck Surg. 2015 Feb;152(1 Suppl):S1-43. doi: 10.1177/0194599814561600.

PMID:
25644617
6.
7.

Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: an open-label study.

Dogru M, Ozmen A, Ertürk H, Sanli O, Karatas A.

Clin Ther. 2002 Aug;24(8):1309-21.

PMID:
12240781
8.

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.

Lanier BQ, Finegold I, D'Arienzo P, Granet D, Epstein AB, Ledgerwood GL.

Curr Med Res Opin. 2004 Aug;20(8):1227-33.

PMID:
15324525
10.

Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar.

Ratner PH, Hampel FC, Amar NJ, van Bavel JH, Mohar D, Marple BF, Roland PS, Wall GM, Brubaker MJ, Drake M, Turner D, Silver LH.

Ann Allergy Asthma Immunol. 2005 Nov;95(5):474-9.

PMID:
16312171
11.
14.

Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis.

Gane J, Buckley R.

J Allergy Clin Immunol Pract. 2013 Jan;1(1):65-74. doi: 10.1016/j.jaip.2012.07.001. Epub 2012 Nov 2. Review.

PMID:
24229824
17.

Prevalence of ocular symptoms in patients with allergic rhinitis: Korean multicenter study.

Lee JE, Kim KR, Rha KS, Dhong HJ, Roh HJ, Rhee CS, Kim KS, Park DJ, Kim SW, Kim YD, Lim SC, Ahn BH, Kang JM, Lee JH, Kim CH, Kim SH, Kim HJ, Lee KH, Cho KS, Jung YH, Lee TH, Shim WS, Kim EJ, Park JS, Lee YS, Kim DY.

Am J Rhinol Allergy. 2013 Sep-Oct;27(5):e135-9. doi: 10.2500/ajra.2013.27.3937.

PMID:
24119594
18.

Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis.

Nickels AS, Dimov V, Wolf R.

Expert Opin Drug Metab Toxicol. 2011 Dec;7(12):1593-9. doi: 10.1517/17425255.2011.630389. Epub 2011 Oct 28. Review.

PMID:
22032416
19.

Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate.

Bielory L.

Ann Allergy Asthma Immunol. 2008 Mar;100(3):272-9. doi: 10.1016/S1081-1206(10)60453-X.

PMID:
18434976

Supplemental Content

Support Center